Hawkins A, Davidson F, Simmonds P
Department of Medical Microbiology, University of Edinburgh, United Kingdom.
J Clin Microbiol. 1997 Jan;35(1):187-92. doi: 10.1128/jcm.35.1.187-192.1997.
The accuracy of different methods for the quantitation of hepatitis C virus in plasma was measured with samples from individuals infected with different genotypes and by using RNA transcripts of predetermined concentrations. Highly reproducible results were observed upon repeat testing of samples by both the original version of the Chiron branched-DNA (bDNA) assay (Quantiplex RNA assay; bDNA-1) and the currently available version (Quantiplex HCV RNA 2.0 assay; bDNA-2). A greater variability was observed in the Roche Monitor assay (correlation coefficient of 0.537, compared with 0.942 and 0.964 for the bDNA-1 and bDNA-2 assays, respectively). Significant differences in the efficiency of detection of genotypes 1, 2, and 3 were observed for the bDNA-1 and Roche Monitor assays, whereas the bDNA-2 assay and nested PCR at limiting dilution were able to quantify genotypes with equal sensitivity. By quantifying RNA transcripts of different genotypes, the sensitivities of the Roche Monitor assay for sequences of the type 2 and type 3 transcripts were estimated to be 11 and 8% of those achieved for genotype 1. When correction factors based upon these results and those from quantitation of circulating viral RNA sequences in samples from blood donors were used, the genotype-specific differences in virus load in samples from blood donors were no longer observed, consistent with previous studies with corrected values from the bDNA-1 assay. These results suggest that many of the previous studies evaluating the effect of genotype and virus load on the response to interferon using methods such as the Roche Monitor assay and other competitive PCR methods require reinterpretation. Differences in efficiency of quantitation should be taken into account in future investigations of the relationship between genotype and virus load.
利用来自感染不同基因型的个体的样本,并通过使用预定浓度的RNA转录本,测定了血浆中丙型肝炎病毒定量的不同方法的准确性。通过Chiron分支DNA(bDNA)检测的原始版本(Quantiplex RNA检测;bDNA-1)和当前可用版本(Quantiplex HCV RNA 2.0检测;bDNA-2)对样本进行重复检测时,观察到了高度可重复的结果。在罗氏监测检测中观察到更大的变异性(相关系数为0.537,而bDNA-1和bDNA-2检测的相关系数分别为0.942和0.964)。对于bDNA-1和罗氏监测检测,观察到在检测1、2和3型基因型的效率上存在显著差异,而bDNA-2检测和有限稀释的巢式PCR能够以相同的灵敏度对基因型进行定量。通过对不同基因型的RNA转录本进行定量,罗氏监测检测对2型和3型转录本序列的灵敏度估计分别为1型转录本灵敏度的11%和8%。当使用基于这些结果以及来自献血者样本中循环病毒RNA序列定量结果的校正因子时,则不再观察到献血者样本中病毒载量的基因型特异性差异,这与之前使用bDNA-1检测校正值的研究结果一致。这些结果表明,许多先前使用罗氏监测检测和其他竞争性PCR方法等评估基因型和病毒载量对干扰素反应影响的研究需要重新解读。在未来关于基因型与病毒载量关系的研究中,应考虑定量效率的差异。